Delivery Order SPE2DB22D2206-SPE2DB25FJH40
- Not listed
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $66,535.75 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.54 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhaler medication for chronic obstructive pulmonary disease treatment). This competitively awarded, non-set-aside contract carries a ceiling value of $13,468.45 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The work will be performed at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,488.46 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a major...
- The Defense Logistics Agency awarded a $40,498.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,345.60 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $6,633.02 to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 5, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,955.40 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 4, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child award issued under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJH40Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,610.69 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), a combination maintenance and reliever asthma and chronic obstructive pulmonary disease medication. This firm fixed-price delivery order, which is not set-aside, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The IDC vehicle enables flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to meet federal medical supply needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/8/25 |